Genix Pharmaceuticals Corp (GENX.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 10/31
| 07-2020 | 04-2020 | 01-2020 | 10-2019 | 07-2019 | |
| Cash Flows From Operating Activities | |||||
| Accounts receivable | -2 | N/A | N/A | 40 | 33 |
| Accounts payable and accrued liabilities | -92 | 143 | -12 | -52 | N/A |
| Other Working Capital | -74 | 172 | -8 | -34 | -31 |
| Other Operating Activity | 24 | -189 | -25 | 48 | -32 |
| Operating Cash Flow | $-144 | $127 | $-45 | $2 | $-30 |
| Cash Flows From Investing Activities | |||||
| Other Investing Activity | 0 | -1,258 | 20 | 0 | 0 |
| Investing Cash Flow | $0 | $-1,258 | $20 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 704 | N/A | N/A | N/A | N/A |
| Financing Cash Flow | $704 | $N/A | $N/A | $N/A | $N/A |
| Beginning Cash Position | 0 | 6 | 31 | 9 | 14 |
| End Cash Position | 561 | 0 | 6 | 31 | 9 |
| Net Cash Flow | $560 | $-6 | $-25 | $22 | $-30 |
| Free Cash Flow | |||||
| Operating Cash Flow | -144 | 127 | -45 | 2 | -30 |
| Free Cash Flow | -144 | 127 | -45 | 2 | -30 |